Important Medical & Legal Disclaimer
### 1. Summary
MHT Assessment is a digital health application designed to support the structured assessment of menopause-related health information. Depending on the features used, the app may display symptom summaries, risk factors, eligibility or suitability categories, contraindication-related flags, treatment-related information, explanatory rationales, and follow-up information.
The app is intended to support informed discussions and clinical assessment. It does not replace a qualified healthcare professional’s independent clinical judgment, a physical examination, appropriate investigations, or an individualised treatment decision.
Do not start, stop, or change any medication or treatment solely on the basis of an app result.
### 2. Purpose and Intended Use
MHT Assessment organises information entered by the user and processes it through its implemented assessment rules and calculations to produce structured outputs.
These outputs are intended to support the assessment and discussion of menopause-related health concerns. The app’s suitability categories, risk flags, explanations, and treatment-related information must be interpreted in the context of the individual’s medical history, examination findings, investigations, preferences, and applicable clinical guidance.
The app must not be used as the sole basis for diagnosing a disease, excluding a serious condition, or determining that a treatment is safe for a particular individual.
### 3. Regulatory Status
MHT Assessment does not claim approval, authorisation, certification, or endorsement by the US Food and Drug Administration (FDA), the UK Medicines and Healthcare products Regulatory Agency (MHRA), the European Union, Health Canada, India's Central Drugs Standard Control Organisation (CDSCO), or any other regulatory authority unless expressly documented and applicable.
The app’s regulatory classification depends on its actual functionality, intended purpose, claims, and the laws applicable in each jurisdiction. No blanket exemption or non-medical-device classification is asserted by this disclaimer.
Users and healthcare professionals should not interpret the availability of the app in an app store or play store as evidence of regulatory approval or proof of clinical effectiveness.
### 4. Intended-Use Boundaries
MHT Assessment is a software-based assessment and information tool. Its outputs may include structured clinical information and decision-support content.
The app is not a substitute for professional assessment or emergency care. Its limitations include dependence on the accuracy and completeness of user-entered information, the scope of its implemented rules, and the clinical evidence incorporated into its design.
The absence of a warning, contraindication flag, or risk indicator does not establish that a condition is absent or that a treatment is safe.
No claim of exemption under a general-wellness, low-risk software, or similar regulatory category is made unless independently established for the relevant jurisdiction and functionality.
### 5. Cross-Border Use
Clinical practice, medicine availability, prescribing requirements, privacy laws, and medical-device regulations differ between countries and regions.
Clinical information displayed by MHT Assessment may not reflect every local guideline, regulatory requirement, or available treatment option. Users and healthcare professionals are responsible for applying relevant local requirements and exercising appropriate clinical judgment.
Availability in a particular country or app store and play store may not establish compliance with every local legal or regulatory requirement.
### 6. Clinical References and Guideline Sources
The app’s clinical content may be informed by published professional guidelines, consensus statements, and other evidence-based resources, where applicable to the implemented feature.
Potential reference sources include:
- International Menopause Society (IMS) guidance.
- North American Menopause Society (NAMS) guidance and position statements, now published under The Menopause Society.
- National Institute for Health and Care Excellence (NICE) guidance, including NG23.
- World Health Organization (WHO) publications relevant to menopause and digital health.
- International Society of Hypertension (ISH) guidance.
- WHO and other recognised guidance on body mass index and relevant population-specific considerations.
- Applicable Indian data-protection legislation, including the Digital Personal Data Protection Act, 2023, where relevant.
The inclusion of an organisation or publication in this list does not establish that every recommendation in the app has been directly derived from, endorsed by, or validated against that source. Specific recommendations should be traceable to the sources and versions actually used in the implemented clinical rules.
### 7. Evidence Updates and Clinical Currency
Clinical recommendations, regulatory requirements, and published evidence may change over time. Although the app may be updated to reflect relevant changes, there may be a delay between the publication of new evidence and implementation within the app.
Users should verify material clinical decisions against current, authoritative guidance. Where the app’s information conflicts with current applicable guidance or an individual’s clinical circumstances, the matter should be reviewed by a qualified healthcare professional.
The app does not guarantee that every output reflects the latest available evidence at the time it is viewed.
### 8. Assessment Logic and Calculation Limitations
MHT Assessment uses implemented software rules and calculations to generate structured assessment outputs. Where applicable, these may include classifications, risk flags, symptom summaries, eligibility categories, explanatory rationales, and follow-up information.
A structured or rule-based result is not proof of diagnostic accuracy, clinical effectiveness, or patient safety. The output may be affected by incomplete, inaccurate, inconsistent, or outdated information; limitations in the implemented rules; and clinical circumstances not represented in the assessment.
The app should not be assumed to predict an individual’s future health outcomes or identify every possible contraindication, complication, or alternative diagnosis.
No claim of zero errors, zero missed contraindications, or zero false escalations is made without adequate supporting validation evidence.
### 9. Data Protection and Storage
The app’s collection, use, storage, transmission, and deletion of information are governed by its actual implementation and the applicable privacy policy and laws.
Any statement that information remains exclusively on the device, that no information is transmitted externally, that no analytics or advertising SDKs are present, or that data are protected using a specific encryption standard must be supported by verification of the relevant app versions, platform behaviour, third-party SDKs, backups, logs, and network activity.
Users should review the app’s current privacy policy for details of data handling, permissions, retention, and applicable rights.
This disclaimer does not independently guarantee that all information is stored locally, encrypted using AES-256, or inaccessible to third parties. Some professional information is shared with 3rd party to manage the app, and none of the clinically related data is shared with any of 3rd party.
### 10. Data Export, Sharing, and Deletion
Where the app provides export, sharing, backup, or similar features, users should review the destination and contents before transferring information.
Once information is exported, shared, backed up, or transferred to another application, device, person, or service, its subsequent handling may be outside the app’s control and may be governed by separate terms and privacy practices.
Users should take appropriate precautions when exporting or sharing sensitive health information, particularly information that identifies a patient or healthcare professional.
Any claim about permanent deletion, backup removal, or data recovery must reflect the app’s actual implementation and the applicable platform behaviour.
### 11. Artificial Intelligence and Automated Processing
Descriptions of the app’s use or non-use of artificial intelligence must match its actual implementation.
Where outputs are generated through deterministic rules and calculations, they should be understood as the results of those implemented rules rather than as independent clinical judgments.
The presence of structured explanations or automated assessment outputs does not, by itself, establish that the result is correct, complete, or appropriate for a particular patient.
### 12. Clinical Oversight and Professional Responsibility
Healthcare professionals using MHT Assessment remain responsible for independently evaluating the patient, reviewing the relevant history and examination findings, ordering or interpreting investigations where appropriate, and making individualised clinical decisions.
An app-generated result should be considered alongside, rather than instead of, professional assessment. Clinical decisions should account for contraindications, comorbidities, concurrent medications, patient preferences, treatment goals, and relevant local guidance.
The app must not be used to justify a clinical decision that would otherwise be inappropriate for the individual.
### 13. User Responsibility and Input Accuracy
Users are responsible for entering information as accurately and completely as possible. Incorrect, incomplete, outdated, or misunderstood information may affect the assessment output.
Users should correct inaccurate information or incorrect input and seek professional clarification when a result appears inconsistent with their symptoms or medical history.
A result that identifies no risk factor or contraindication must not be interpreted as confirmation that no risk exists. Likewise, a result indicating suitability or eligibility does not independently establish that a treatment is appropriate or safe.
### 14. Third-Party Clinical References and Resources
The app may refer to external publications, professional organisations, clinical guidance, or other third-party resources.
Such references are provided for informational context. Unless expressly documented, their inclusion does not imply endorsement of MHT Assessment by the relevant organisation or author.
External resources may change, become unavailable, or be updated independently of the app. Users should consult the source when a reference is material to a clinical decision.
### 15. Accessibility and Usability
The app is intended to present information in a usable and understandable format. However, no claim of full compliance with WCAG 2.2 Level AA or any other accessibility standard should be inferred unless supported by appropriate accessibility testing and documented results.
Display, readability, navigation, and assistive-technology compatibility may vary by device, operating system, display settings, and accessibility configuration.
Users who encounter accessibility barriers should use available platform accessibility features and contact the developer to report the issue.
### 16. Emergencies and Urgent Medical Attention
MHT Assessment is not an emergency response service and must not be used to determine whether urgent medical care is necessary.
Seek emergency medical assistance for symptoms such as chest pain, severe or sudden breathlessness, fainting with concerning symptoms, signs of stroke, or other potentially life-threatening symptoms.
Unexpected or heavy vaginal bleeding, bleeding after menopause, or other concerning symptoms require prompt medical assessment. Severe bleeding or bleeding accompanied by collapse, marked weakness, severe pain, or other signs of instability requires emergency assessment.
Do not delay contacting emergency services or obtaining medical care while completing an assessment, reviewing an app result, or waiting for a follow-up.
### 17. Language and Localisation
The availability and accuracy of app content may vary by language, region, and local clinical practice. Where the app is available only in English, its content may not be suitable for users who cannot reliably understand English.
Clinical terminology, medicine names, units, and guideline recommendations may have different interpretations across regions. Users should seek clarification when information is unclear or does not match local practice.
No claim of comprehensive localisation or translation accuracy is made unless verified for the relevant version.
### 18. Third-Party Services and Platform Dependencies
MHT Assessment may rely on third-party services and platform components to support app distribution, in-app purchases, subscription management, payments, export, and sharing.
**RevenueCat** is used to support subscription management and subscription-status verification, where enabled. In connection with these functions, RevenueCat may process subscription-related information, such as app user identifiers, purchase or transaction information, subscription status, and technical information, depending on the app’s configuration.
Apple App Store and Google Play provide their respective in-app purchase and payment infrastructure. Information associated with purchases may be processed by these platforms and by RevenueCat to facilitate subscription management.
RevenueCat is used for subscription-related functionality, and no clinical data of patient assessment records or clinical information is shared with the 3rd party provider like RevenueCat.
Third-party services operate under their own terms and privacy policies. Their availability, data-handling practices, and service limitations may change independently of MHT Assessment.
For further information, users may review the [RevenueCat Privacy Policy](https://www.revenuecat.com/privacy), the applicable Apple or Google privacy information, and the MHT Assessment Privacy Policy.
### 19. Limitation of Liability
To the extent permitted by applicable law, the developer is not responsible for decisions made solely on the basis of an app-generated result without appropriate consideration of the individual’s clinical circumstances with professional clinican.
Nothing in this disclaimer excludes or limits liability where such exclusion or limitation is prohibited by law, including any applicable non-excludable consumer rights or liability for which the law does not permit exclusion.
This disclaimer does not create a guarantee of clinical accuracy, uninterrupted availability, suitability for a particular purpose, or freedom from software defects.
Users and healthcare professionals should exercise appropriate judgment and use the app within its stated intended purpose.
### 20. Updates and Changes
The app, its assessment logic, clinical references, features, privacy practices, and this disclaimer may be revised over time.
A change in app version does not, by itself, establish that every clinical rule has been revalidated or that all regulatory, privacy, or accessibility requirements have been independently reassessed.
Users should review relevant release notes, privacy information, and updated disclaimer versions when provided.
Material changes to clinical functionality, intended purpose, or data handling should be reflected in the applicable documentation and disclosures.
### 21. Developer and Contact Information
**App Name:** MHT Assessment
**Developer/Responsible Contact:** Mr Vaibhav Shrivastava
**Email:** careteam.mht@hotmail.com
**Primary Jurisdiction:** India
The developer contact details and any designated data-protection or privacy contact must be kept current and must accurately reflect the responsibilities assigned under applicable law.
The designation of a person as a contact or data steward does not, by itself, establish legal compliance or confer a particular statutory role.
### 22. Governing Law and Jurisdiction
To the extent permitted by applicable law, the use of MHT Assessment and disputes concerning the app may be governed by the laws of India.
Any exclusive jurisdiction clause must be reviewed for enforceability and must not override mandatory consumer-protection, privacy, healthcare, or other statutory rights that apply in the user’s jurisdiction.
Nothing in this section is intended to remove rights or remedies that cannot lawfully be excluded.
### 23. App Store and Platform Declarations
MHT Assessment’s app descriptions, store category, intended-use statements, medical and health declarations, privacy disclosures, subscription terms, and other platform metadata must accurately reflect the app’s actual functionality and intended purpose.
Classification under a category such as “Health & Fitness (Google Play) and medical (Apple App store) ” or describing the app as educational does not by itself establish that the app falls outside applicable medical-device or clinical decision-support regulations.
The developer is responsible for ensuring that declarations and representations made to Apple, Google, users, and relevant regulatory authorities are accurate, consistent, and supported by the app’s implemented functionality and available evidence.
Statements that MHT Assessment does not diagnose medical conditions, prescribe medication, recommend treatment, or provide clinical decision support must be assessed against the app’s actual features and outputs before publication. Where the app provides risk classifications, suitability assessments, contraindication-related flags, or treatment-related recommendations, these functions must be described accurately in the relevant disclosures.
App-store acceptance or availability does not, by itself, establish regulatory approval, clinical validation, or compliance with all applicable legal requirements.
### 24. Disclaimer Version and Release Traceability
**Disclaimer Version:** 1.2
**Proposed Effective Date:** 12 October 2026
These details must be confirmed against the version of the disclaimer actually published and the app release to which it applies. The effective date should reflect the actual publication or adoption date.
The previous disclaimer version should be retained in the developer’s documentation for traceability, together with a record of material changes where appropriate.
This section does not certify that the app version, clinical rules, privacy implementation, or regulatory status has been independently audited by any 3rd party.
### 25. Final Notice
By using MHT Assessment, users acknowledge that software-generated assessment information has limitations and must be interpreted in the context of the individual’s circumstances.
The app is intended to support assessment and informed discussion; it does not replace professional clinical judgment, appropriate investigations, or urgent medical care.
Where an app output conflicts with clinical findings, current applicable guidance, or a qualified healthcare professional’s assessment, the matter should be reviewed rather than relying on the app result alone.
**Please read this disclaimer together with the app’s current privacy policy, terms of use, and applicable platform disclosures.**
---
**Last updated on:**- 12-October-2026 (2:31 AM IST)
**Disclaimer Version:** -1.2